Avita Medical Inc. (AVH:ASX)


right-arrow Created with Sketch. -0.37 (-7.27%)
MCAP $728.5M
Last trade 16.10pm 17/09/2021 20mins delayed

Latest Announcements

14/09/2021AVHAvita Medical Inc.
09/09/2021AVHAvita Medical Inc.
09/09/2021AVHAvita Medical Inc.
09/09/2021AVHAvita Medical Inc.
07/09/2021AVHAvita Medical Inc.
03/09/2021 Price SensitivePSAVHAvita Medical Inc.
03/09/2021AVHAvita Medical Inc.
01/09/2021AVHAvita Medical Inc.

Company Overview

AVITA Medical Inc., formerly AVITA Therapeutics, Inc., is a regenerative medicine company with a technology platform to address medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications. Its technology provides treatment solutions derived from the regenerative properties of a patient’s own skin. The medical devices work by preparing Spray-On Skin Cells, an autologous cellular suspension comprised of the patient’s skin cells necessary to regenerate natural healthy epidermis. It has developed RECELL System, a product for the treatment of acute thermal burn injuries in patients 18 years and older. The RECELL System is used to prepare Spray-On Skin Cells using a small amount of a patient’s own skin, providing a way to treat severe burns that significantly reduces the amount of donor skin required. It can be used at the point of care alone or in combination with split-thickness skin autografts depending on the depth of the burn injury.

AVH in the news

The US Food and Drug Administration (FDA) approves change to Avita Medical’s…
Avita Medical (AVH) is included in the Russell 3000 Index as part…
Avita Medical (AVH) increases its fourth-quarter revenue guidance thanks to the strength…
The US regulator approves the expanded use of Avita Medical’s (AVH) RECELL…

Search Previous Announcements